October 26, 2007
So when Sharfstein became Baltimore’s health commissioner, he launched a campaign that led an expert panel of the Food and Drug Administration to conclude last week that the products should not be used in children younger than 6, shocking many parents and setting up a possible clash between the FDA and the pharmaceutical industry, which is vowing to continue selling the products.The case has also raised many questions: How could the products remain on the market for so long without proof they work? Why didn’t the FDA act sooner? Why didn’t the medical establishment warn parents? Are there other medications in a similar situation?